Influenza Vaccine Market & Forecast in (West Europe) Netherlands, Germany, France, Ireland, Luxembourg, Poland and United Kingdom By (Child & Adult)
Influenza vaccine market for West Europe was more than US$ 500 Million. United Kingdom is having the highest seasonal influenza vaccine market share followed by Germany and France respectively. In children vaccination, United Kingdom is the leader and France holds the second spot. In adult vaccination United Kingdom and Germany have a close fight for top slot.
Influenza Vaccine Market & Forecast in (West Europe) Netherlands, Germany, France, Ireland, Luxembourg, Poland and United Kingdom By (Child & Adult) is a report published by Renub Research. In total 7 Europe Countries influenza vaccine market and its vaccinated population numbers have been captured in the report. All the 7 Europe countries are as follows: Netherlands, Germany, France, Ireland, Luxembourg, Poland and United Kingdom.
Scope of Study
1. Netherlands
2. Germany
3. France
4. Ireland
5. Luxembourg
6. Poland
7. United Kingdom
Influenza Vaccine Market & Forecast in (West Europe) Netherlands, Germany, France, Ireland, Luxembourg, Poland and United Kingdom By (Child & Adult) is a report published by Renub Research. In total 7 Europe Countries influenza vaccine market and its vaccinated population numbers have been captured in the report. All the 7 Europe countries are as follows: Netherlands, Germany, France, Ireland, Luxembourg, Poland and United Kingdom.
Scope of Study
- Influenza Vaccine Market & Forecast has been sub divided into two segments Children Influenza Vaccine Market & Forecast and Adult Influenza Vaccine Market & Forecast.
- Influenza Vaccine Market share & Forecast, Children Influenza Vaccine Market share & Forecast and Adult Influenza Vaccine Market share & Forecast.
- Influenza Vaccinated Population & Forecast has been sub divided into two segments Children Influenza Vaccinated Population & Forecast and Adult Influenza Vaccinated Population & Forecast.
- What is the Influenza Vaccine Market in Netherlands, Germany, France, Ireland, Luxembourg, Poland and United Kingdom?
- What is the Children Influenza Vaccine Market in Poland, Germany, Netherlands, France, Luxembourg, Ireland, and United Kingdom?
- What is the Adult Influenza Vaccine Market in United Kingdom, France, Luxembourg, Ireland, Germany, Poland and Netherlands?
- What is the Influenza Vaccinated Population & Forecast in Netherlands, Germany, France, Ireland, Luxembourg, Poland and United Kingdom?
- What is the Influenza Vaccinated Population & Forecast for Children in Poland, Germany, Netherlands, France, Luxembourg, Ireland, and United Kingdom?
- What is the Influenza Vaccinated Population & Forecast for Adult in United Kingdom, France, Luxembourg, Ireland, Germany, Poland and Netherlands?
1. Netherlands
2. Germany
3. France
4. Ireland
5. Luxembourg
6. Poland
7. United Kingdom
1. EXECUTIVE SUMMARY
2. WESTERN EUROPE COUNTRIES SEASONAL INFLUENZA VACCINATED TOTAL POPULATION
2.1 Seasonal Influenza Vaccinated Child Population in Western Europe Countries
2.2 Seasonal Influenza Vaccinated Adult Population in Western Europe Countries
3. WESTERN EUROPE COUNTRIES SEASONAL INFLUENZA VACCINE MARKET
3.1 Seasonal Influenza Child Vaccine Market in Western Europe Countries
3.2 Seasonal Influenza Adult Vaccine Market in Western Europe Countries
4. WESTERN EUROPE COUNTRIES SEASONAL INFLUENZA VACCINE MARKET SHARE
4.1 Western Europe Countries Seasonal Influenza Vaccine Market Share
4.2 Western Europe Countries Seasonal Influenza Child Vaccine Market Share
4.3 Western Europe Countries Seasonal Influenza Adult Vaccine Market Share
5. NETHERLANDS
5.1 Netherlands Seasonal Influenza Vaccinated Total Population
5.1.1 Netherlands Seasonal Influenza Vaccinated Child Population
5.1.2 Netherlands Seasonal Influenza Vaccinated Adult Population
5.2 Netherlands Seasonal Influenza Vaccine Market
5.2.1 Netherlands Seasonal Influenza Child Vaccine Market
5.2.2 Netherlands Seasonal Influenza Adult Vaccine Market
6. GERMANY
6.1 Germany Seasonal Influenza Vaccinated Total Population
6.1.1 Germany Seasonal Influenza Vaccinated Child Population
6.1.2 Germany Seasonal Influenza Vaccinated Adult Population
6.2 Germany Seasonal Influenza Vaccine Market
6.2.1 Germany Seasonal Influenza Child Vaccine Market
6.2.2 Germany Seasonal Influenza Adult Vaccine Market
7. FRANCE
7.1 France Seasonal Influenza Vaccinated Total Population
7.1.1 France Seasonal Influenza Vaccinated Child Population
7.1.2 France Seasonal Influenza Vaccinated Adult Population
7.2 France Seasonal Influenza Vaccine Market Analysis
7.2.1 France Seasonal Influenza Child Vaccine Market
7.2.2 France Seasonal Influenza Adult Vaccine Market
8. IRELAND
8.1 Ireland Seasonal Influenza Vaccinated Total Population
8.1.1 Ireland Seasonal Influenza Vaccinated Child Population
8.1.2 Ireland Seasonal Influenza Vaccinated Adult Population
8.2 Ireland Seasonal Influenza Vaccine Market
8.2.1 Ireland Seasonal Influenza Child Vaccine Market
8.2.2 Ireland Seasonal Influenza Adult Vaccine Market
9. LUXEMBOURG
9.1 Luxembourg Seasonal Influenza Vaccinated Total Population
9.1.1 Luxembourg Seasonal Influenza Vaccinated Child Population
9.1.2 Luxembourg Seasonal Influenza Vaccinated Adult Population
9.2 Luxembourg Seasonal Influenza Vaccine Market
9.2.1 Luxembourg Seasonal Influenza Child Vaccine Market
9.2.2 Luxembourg Seasonal Influenza Adult Vaccine Market
10. POLAND
10.1 Poland Seasonal Influenza Vaccinated Total Population
10.1.1 Poland Seasonal Influenza Vaccinated Child Population
10.1.2 Poland Seasonal Influenza Vaccinated Adult Population
10.2 Poland Seasonal Influenza Vaccine Market
10.2.1 Poland Seasonal Influenza Child Vaccine Market
10.2.2 Poland Seasonal Influenza Adult Vaccine Market
11. UNITED KINGDOM
11.1 United Kingdom Seasonal Influenza Vaccinated Total Population
11.1.1 United Kingdom Seasonal Influenza Vaccinated Child Population
11.1.2 United Kingdom Seasonal Influenza Vaccinated Adult Population
11.2 United Kingdom Seasonal Influenza Vaccine Market
11.2.1 United Kingdom Seasonal Influenza Child Vaccine Market
11.2.2 United Kingdom Seasonal Influenza Adult Vaccine Market
12. SEASONAL INFLUENZA VACCINE - GROWTH DRIVERS
12.1 Vaccine Manufacturers Plan to Increase Flu Vaccine Production
12.2 Growing Child & Ageing Population in Western European Region
12.3 Rising Healthcare Expenditure Share of the Western Europe Countries GDP
13. SEASONAL INFLUENZA VACCINE – CHALLENGES
13.1 Regulatory Challenges with New and Novel Influenza Vaccines
13.2 Lack of Healthcare Infrastructure
13.3 Limited Reimbursement and Access to the Vaccines
2. WESTERN EUROPE COUNTRIES SEASONAL INFLUENZA VACCINATED TOTAL POPULATION
2.1 Seasonal Influenza Vaccinated Child Population in Western Europe Countries
2.2 Seasonal Influenza Vaccinated Adult Population in Western Europe Countries
3. WESTERN EUROPE COUNTRIES SEASONAL INFLUENZA VACCINE MARKET
3.1 Seasonal Influenza Child Vaccine Market in Western Europe Countries
3.2 Seasonal Influenza Adult Vaccine Market in Western Europe Countries
4. WESTERN EUROPE COUNTRIES SEASONAL INFLUENZA VACCINE MARKET SHARE
4.1 Western Europe Countries Seasonal Influenza Vaccine Market Share
4.2 Western Europe Countries Seasonal Influenza Child Vaccine Market Share
4.3 Western Europe Countries Seasonal Influenza Adult Vaccine Market Share
5. NETHERLANDS
5.1 Netherlands Seasonal Influenza Vaccinated Total Population
5.1.1 Netherlands Seasonal Influenza Vaccinated Child Population
5.1.2 Netherlands Seasonal Influenza Vaccinated Adult Population
5.2 Netherlands Seasonal Influenza Vaccine Market
5.2.1 Netherlands Seasonal Influenza Child Vaccine Market
5.2.2 Netherlands Seasonal Influenza Adult Vaccine Market
6. GERMANY
6.1 Germany Seasonal Influenza Vaccinated Total Population
6.1.1 Germany Seasonal Influenza Vaccinated Child Population
6.1.2 Germany Seasonal Influenza Vaccinated Adult Population
6.2 Germany Seasonal Influenza Vaccine Market
6.2.1 Germany Seasonal Influenza Child Vaccine Market
6.2.2 Germany Seasonal Influenza Adult Vaccine Market
7. FRANCE
7.1 France Seasonal Influenza Vaccinated Total Population
7.1.1 France Seasonal Influenza Vaccinated Child Population
7.1.2 France Seasonal Influenza Vaccinated Adult Population
7.2 France Seasonal Influenza Vaccine Market Analysis
7.2.1 France Seasonal Influenza Child Vaccine Market
7.2.2 France Seasonal Influenza Adult Vaccine Market
8. IRELAND
8.1 Ireland Seasonal Influenza Vaccinated Total Population
8.1.1 Ireland Seasonal Influenza Vaccinated Child Population
8.1.2 Ireland Seasonal Influenza Vaccinated Adult Population
8.2 Ireland Seasonal Influenza Vaccine Market
8.2.1 Ireland Seasonal Influenza Child Vaccine Market
8.2.2 Ireland Seasonal Influenza Adult Vaccine Market
9. LUXEMBOURG
9.1 Luxembourg Seasonal Influenza Vaccinated Total Population
9.1.1 Luxembourg Seasonal Influenza Vaccinated Child Population
9.1.2 Luxembourg Seasonal Influenza Vaccinated Adult Population
9.2 Luxembourg Seasonal Influenza Vaccine Market
9.2.1 Luxembourg Seasonal Influenza Child Vaccine Market
9.2.2 Luxembourg Seasonal Influenza Adult Vaccine Market
10. POLAND
10.1 Poland Seasonal Influenza Vaccinated Total Population
10.1.1 Poland Seasonal Influenza Vaccinated Child Population
10.1.2 Poland Seasonal Influenza Vaccinated Adult Population
10.2 Poland Seasonal Influenza Vaccine Market
10.2.1 Poland Seasonal Influenza Child Vaccine Market
10.2.2 Poland Seasonal Influenza Adult Vaccine Market
11. UNITED KINGDOM
11.1 United Kingdom Seasonal Influenza Vaccinated Total Population
11.1.1 United Kingdom Seasonal Influenza Vaccinated Child Population
11.1.2 United Kingdom Seasonal Influenza Vaccinated Adult Population
11.2 United Kingdom Seasonal Influenza Vaccine Market
11.2.1 United Kingdom Seasonal Influenza Child Vaccine Market
11.2.2 United Kingdom Seasonal Influenza Adult Vaccine Market
12. SEASONAL INFLUENZA VACCINE - GROWTH DRIVERS
12.1 Vaccine Manufacturers Plan to Increase Flu Vaccine Production
12.2 Growing Child & Ageing Population in Western European Region
12.3 Rising Healthcare Expenditure Share of the Western Europe Countries GDP
13. SEASONAL INFLUENZA VACCINE – CHALLENGES
13.1 Regulatory Challenges with New and Novel Influenza Vaccines
13.2 Lack of Healthcare Infrastructure
13.3 Limited Reimbursement and Access to the Vaccines
LIST OF FIGURES
Figure 2 1: Western Europe Countries - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 2 2: Western Europe Countries – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 2 3: Western Europe Countries - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 2 4: Western Europe Countries – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 2 5: Western Europe Countries - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 2 6: Western Europe Countries – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 3 1: Western Europe Countries - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 3 2: Western Europe Countries – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 3 3: Western Europe Countries - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 3 4: Western Europe Countries – Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 3 5: Western Europe Countries - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 3 6: Western Europe Countries – Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 5 1: Netherlands - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 5 2: Netherlands – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 5 3: Netherlands - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 5 4: Netherlands – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 5 5: Netherlands - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 5 6: Netherlands – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 5 7: Netherlands - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 8: Netherlands – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 5 9: Netherlands - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 10: Netherlands – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 5 11: Netherlands - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 12: Netherlands – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 1: Germany – Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 6 2: Germany - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 6 3: Germany – Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 6 4: Germany - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 6 5: Germany – Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 6 6: Germany - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 6 7: Germany – Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 6 8: Germany - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 – 2022
Figure 6 9: Germany – Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 6 10: Germany - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 6 11: Germany- Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 6 12: Germany- Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 7 1: France – Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 7 2: France - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 7 3: France - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 7 4: France- Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 7 5: France - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 7 6: France - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 7 7: France - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 7 8: France - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 7 9: France - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 7 10: France - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 7 11: France - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 7 12: France - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 – 2022
Figure 8 1: Ireland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 8 2: Ireland – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 8 3: Ireland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 8 4: Ireland – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 8 5: Ireland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 8 6: Ireland – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 8 7: Ireland - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 8 8: Ireland – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 8 9: Ireland - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 8 10: Ireland – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 8 11: Ireland - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 – 2016
Figure 8 12: Ireland – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 – 2022
Figure 9 1: Luxembourg - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 9 2: Luxembourg – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 9 3: Luxembourg - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 9 4: Luxembourg – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 9 5: Luxembourg - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 9 6: Luxembourg – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 9 7: Luxembourg - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 9 8: Luxembourg – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 – 2022
Figure 9 9: Luxembourg - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 9 10: Luxembourg – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 9 11: Luxembourg - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 -2016
Figure 9 12: Luxembourg – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 -2022
Figure 10 1: Poland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 – 2016
Figure 10 2: Poland- Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 10 3: Poland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 10 4: Poland - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 10 5: Poland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 10 6: Poland - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 10 7: Poland - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 10 8: Poland - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 10 9: Poland - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 10 10: Poland - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 10 11: Poland - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 10 12: Poland - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017- 2022
Figure 11 1: United Kingdom - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 11 2: United Kingdom – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 11 3: United Kingdom - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 11 4: United Kingdom – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 11 5: United Kingdom - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 11 6: United Kingdom – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 11 7: List of Seasonal Influenza Vaccines for the 2016/17 Influenza Season
Figure 11 8: United Kingdom - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 11 9: United Kingdom – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 11 10: United Kingdom - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 11 11: United Kingdom – Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 11 12: United Kingdom - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 11 13: United Kingdom – Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 12 1: Vaccine Manufacturers – Influenza Vaccine Production (Million Doses), 2013-2015
Figure 13 1: Worldwide - Hospital Beds (Number) per Thousand, 2014 - 2019
Figure 2 1: Western Europe Countries - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 2 2: Western Europe Countries – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 2 3: Western Europe Countries - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 2 4: Western Europe Countries – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 2 5: Western Europe Countries - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 2 6: Western Europe Countries – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 3 1: Western Europe Countries - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 3 2: Western Europe Countries – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 3 3: Western Europe Countries - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 3 4: Western Europe Countries – Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 3 5: Western Europe Countries - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 3 6: Western Europe Countries – Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 5 1: Netherlands - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 5 2: Netherlands – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 5 3: Netherlands - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 5 4: Netherlands – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 5 5: Netherlands - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 5 6: Netherlands – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 5 7: Netherlands - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 8: Netherlands – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 5 9: Netherlands - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 10: Netherlands – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 5 11: Netherlands - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 12: Netherlands – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 1: Germany – Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 6 2: Germany - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 6 3: Germany – Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 6 4: Germany - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 6 5: Germany – Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 6 6: Germany - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 6 7: Germany – Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 6 8: Germany - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 – 2022
Figure 6 9: Germany – Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 6 10: Germany - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 6 11: Germany- Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 6 12: Germany- Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 7 1: France – Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 7 2: France - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 7 3: France - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 7 4: France- Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 7 5: France - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 7 6: France - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 7 7: France - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 7 8: France - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 7 9: France - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 7 10: France - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 7 11: France - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 7 12: France - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 – 2022
Figure 8 1: Ireland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 8 2: Ireland – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 8 3: Ireland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 8 4: Ireland – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 8 5: Ireland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 8 6: Ireland – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 8 7: Ireland - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 8 8: Ireland – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 8 9: Ireland - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 8 10: Ireland – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 8 11: Ireland - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 – 2016
Figure 8 12: Ireland – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 – 2022
Figure 9 1: Luxembourg - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 9 2: Luxembourg – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 9 3: Luxembourg - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 9 4: Luxembourg – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 9 5: Luxembourg - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 9 6: Luxembourg – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 9 7: Luxembourg - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 9 8: Luxembourg – Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 – 2022
Figure 9 9: Luxembourg - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 9 10: Luxembourg – Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 9 11: Luxembourg - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 -2016
Figure 9 12: Luxembourg – Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 -2022
Figure 10 1: Poland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 – 2016
Figure 10 2: Poland- Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 10 3: Poland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 10 4: Poland - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 10 5: Poland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 10 6: Poland - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 10 7: Poland - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 10 8: Poland - Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 10 9: Poland - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 10 10: Poland - Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 10 11: Poland - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 10 12: Poland - Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017- 2022
Figure 11 1: United Kingdom - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 11 2: United Kingdom – Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 11 3: United Kingdom - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 11 4: United Kingdom – Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 11 5: United Kingdom - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 11 6: United Kingdom – Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 11 7: List of Seasonal Influenza Vaccines for the 2016/17 Influenza Season
Figure 11 8: United Kingdom - Seasonal Influenza Vaccine Market (Million US$), 2011 - 2016
Figure 11 9: United Kingdom – Forecast for Seasonal Influenza Vaccine Market (Million US$), 2017 - 2022
Figure 11 10: United Kingdom - Seasonal Influenza Child Vaccine Market (Million US$), 2011 - 2016
Figure 11 11: United Kingdom – Forecast for Seasonal Influenza Child Vaccine Market (Million US$), 2017 - 2022
Figure 11 12: United Kingdom - Seasonal Influenza Adult Vaccine Market (Million US$), 2011 - 2016
Figure 11 13: United Kingdom – Forecast for Seasonal Influenza Adult Vaccine Market (Million US$), 2017 - 2022
Figure 12 1: Vaccine Manufacturers – Influenza Vaccine Production (Million Doses), 2013-2015
Figure 13 1: Worldwide - Hospital Beds (Number) per Thousand, 2014 - 2019
LIST OF TABLES
Table 4 1: Western Europe Countries - Seasonal Influenza Vaccine Market Share (Percent), 2011 - 2016
Table 4 2: Western Europe Countries – Forecast for Seasonal Influenza Vaccine Market Share (Percent), 2017 - 2022
Table 4 3: Western Europe Countries - Seasonal Influenza Child Vaccine Market Share (Percent), 2011 - 2016
Table 4 4: Western Europe Countries – Forecast for Seasonal Influenza Child Vaccine Market Share (Percent), 2017 - 2022
Table 4 5: Western Europe Countries - Seasonal Influenza Adult Vaccine Market Share (Percent), 2011 - 2016
Table 4 6: Western Europe Countries - Seasonal Influenza Adult Vaccine Market Share (Percent), 2017 - 2022
Table 12 1: Western Europe Countries – Child Population (Thousand), 2010 – 2016
Table 12 2: Western Europe Countries – Forecast for Child Population (Thousand), 2017 – 2022
Table 12 3: Western Europe Countries – Ageing Population (Thousand), 2010 – 2016
Table 12 4: Western Europe Countries – Forecast for Ageing Population (Thousand), 2017 – 2022
Table 12 5: Western Europe Countries - Healthcare Expenditure Share (Percent) of GDP, 2005 – 2015
Table 4 1: Western Europe Countries - Seasonal Influenza Vaccine Market Share (Percent), 2011 - 2016
Table 4 2: Western Europe Countries – Forecast for Seasonal Influenza Vaccine Market Share (Percent), 2017 - 2022
Table 4 3: Western Europe Countries - Seasonal Influenza Child Vaccine Market Share (Percent), 2011 - 2016
Table 4 4: Western Europe Countries – Forecast for Seasonal Influenza Child Vaccine Market Share (Percent), 2017 - 2022
Table 4 5: Western Europe Countries - Seasonal Influenza Adult Vaccine Market Share (Percent), 2011 - 2016
Table 4 6: Western Europe Countries - Seasonal Influenza Adult Vaccine Market Share (Percent), 2017 - 2022
Table 12 1: Western Europe Countries – Child Population (Thousand), 2010 – 2016
Table 12 2: Western Europe Countries – Forecast for Child Population (Thousand), 2017 – 2022
Table 12 3: Western Europe Countries – Ageing Population (Thousand), 2010 – 2016
Table 12 4: Western Europe Countries – Forecast for Ageing Population (Thousand), 2017 – 2022
Table 12 5: Western Europe Countries - Healthcare Expenditure Share (Percent) of GDP, 2005 – 2015
